MRP ₹6650
(Inclusive of all Taxes)
₹997.5 Cashback (15%)
Provide Delivery Location
About Baraclude 0.5 mg Oral Solution
Baraclude 0.5 mg Oral Solution is used to treat chronic hepatitis B virus (HBV) infection. Hepatitis B is a severe liver infection caused by the hepatitis B virus (HBV). It is highly contagious and spreads through intimate contact with the infected person and direct contact with infected blood.
Baraclude 0.5 mg Oral Solution contains Entecavir, which helps prevent the virus from replicating and reduces the amount of hepatitis B virus in the body.
Take Baraclude 0.5 mg Oral Solution as advised by the doctor. In some cases, you may experience dizziness, headache, nausea, vomiting, drowsiness, extreme tiredness, inability to sleep, diarrhoea, or indigestion. Most of these side effects do not require medical attention. However, if the side effects worsen, please consult your doctor.
If you are allergic to Baraclude 0.5 mg Oral Solution or any other medicines, please tell your doctor. If you are pregnant or breastfeeding, please consult a doctor before taking Baraclude 0.5 mg Oral Solution . It is recommended to use effective contraceptive methods while using Baraclude 0.5 mg Oral Solution to avoid pregnancy. If you have HIV/AIDS, kidney or liver problems, inform your doctor before taking Baraclude 0.5 mg Oral Solution .
Uses of Baraclude 0.5 mg Oral Solution
Baraclude 0.5 mg Oral Solution is used for the treatment of chronic (long-term) hepatitis B virus (HBV) infection. The detailed uses of Baraclude 0.5 mg Oral Solution are as follows:

Have a query?
Directions for Use
Medicinal Benefits
How Baraclude 0.5 mg Oral Solution Works
Storage
What if I have taken an overdose of Baraclude 0.5 mg Oral Solution
Drug Warnings
Diet & Lifestyle Advise
Healthy eating habits:
Lifestyle changes:
Physical activity
Habit Forming
Therapeutic Class
Alcohol
Consult your doctor
The interaction of alcohol with Baraclude 0.5 mg Oral Solution is unknown. Please consult a doctor before consuming alcohol while using Baraclude 0.5 mg Oral Solution .
Pregnancy
Caution
Baraclude 0.5 mg Oral Solution is a category C pregnancy drug and is given to pregnant women only if the doctor thinks the benefits outweigh the risks.
Breast Feeding
Consult your doctor
It is not known whether Baraclude 0.5 mg Oral Solution is excreted in human breast milk. Therefore, consult your doctor before using Baraclude 0.5 mg Oral Solution while breastfeeding. Your doctor will weigh the potential benefits against the possible risks before recommending its use during this time.
Driving
Caution
Baraclude 0.5 mg Oral Solution may cause dizziness, drowsiness or tiredness in some people. Therefore, avoid driving or operating heavy machinery if you feel dizzy, drowsy or tired after taking Baraclude 0.5 mg Oral Solution .
Liver
Caution
Take Baraclude 0.5 mg Oral Solution with caution, especially if you have liver problems. Your doctor may adjust the dose as required. Please consult a doctor.
Kidney
Caution
Take Baraclude 0.5 mg Oral Solution with caution, especially if you have kidney problems. Your doctor may adjust the dose as required. Please consult a doctor.
Children
Caution
Baraclude 0.5 mg Oral Solution is not recommended for children under 2 years of age or weighing less than 10 kg due to insufficient safety and effectiveness data. In children aged 2 years and above, Baraclude 0.5 mg Oral Solution should be used only under medical supervision, with doses strictly adjusted based on the child’s weight and clinical condition. Close monitoring of treatment response and potential side effects is essential.
Heart
Caution
Baraclude 0.5 mg Oral Solution should be used with caution in patients with heart problems. Therefore, please consult your doctor before using Baraclude 0.5 mg Oral Solution .
Geriatrics
Consult your doctor
Baraclude 0.5 mg Oral Solution is generally safe for geriatric people, but it requires dose adjustments and careful monitoring, particularly in those with age-related kidney impairment. Therefore, please consult your doctor before using Baraclude 0.5 mg Oral Solution .
Baraclude 0.5 mg Oral Solution is an antiviral medication used to treat chronic hepatitis B virus (HBV) infection in adults and children aged 2 to 18 years.
Baraclude 0.5 mg Oral Solution contains Entecavir, an antiviral drug that works by preventing the viral DNA polymerase enzyme action in the liver cells, which is essential for the virus to multiply. Therefore, it prevents the virus from replicating and reduces the amount of hepatitis B virus in the body.
Yes, hepatitis B virus infection is highly contagious and spreads from one person to another. Therefore, it is recommended to avoid sharing personal items or needles containing an infected person's blood or body fluids.
Baraclude 0.5 mg Oral Solution may cause lactic acidosis (excess of lactic acid in the blood), a rare but severe side effect, especially in women who are very obese. However, if you experience stomach pain, vomiting or nausea while taking Baraclude 0.5 mg Oral Solution , please consult a doctor immediately.
You are not recommended to take Baraclude 0.5 mg Oral Solution with celecoxib (painkiller), as it may increase the blood levels of Baraclude 0.5 mg Oral Solution , leading to more adverse effects and may also affect kidney function. However, please consult your doctor before taking Baraclude 0.5 mg Oral Solution with other medicines.
Baraclude 0.5 mg Oral Solution does not cure hepatitis B virus infection. However, it reduces the amount of hepatitis B virus in the body and improves liver functioning by decreasing liver damage.
Baraclude 0.5 mg Oral Solution is not recommended for hepatitis B patients with HIV infection unless they are taking medicines to treat HIV infection at the same time as Baraclude 0.5 mg Oral Solution may cause HIV infection to become resistant to certain HIV drugs and reduce their effectiveness. Therefore, it is advised to get tested for HIV infection before taking Baraclude 0.5 mg Oral Solution .
You are not recommended to stop taking Baraclude 0.5 mg Oral Solution without consulting your doctor, as it may worsen the infection or cause recurring symptoms. Therefore, take Baraclude 0.5 mg Oral Solution for as long as your doctor has prescribed it. If you experience any difficulty while taking Baraclude 0.5 mg Oral Solution , please consult your doctor.
Baraclude 0.5 mg Oral Solution may cause dizziness, headache, nausea, vomiting, drowsiness, extreme tiredness, inability to sleep, diarrhoea, or indigestion. Most of these side effects do not require medical attention. However, if the side effects worsen, please consult your doctor.
Country of origin
Manufacturer/Marketer address